Valeo Pharma Inc. at its annual general meeting held on April 27, 2022, announced the appointment of Marc Léger as director of the Company. Mr. Léger is a seasoned pharmaceutical executive with pan-Canadian and U.S. experience in both the prescription pharmaceutical and consumer healthcare businesses. He has extensive experience in building and leading organizations and has an excellent track record of developing best in class brands.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 CAD | -22.58% | -22.58% | -33.33% |
Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
Mar. 15 | Transcript : Valeo Pharma Inc., Q1 2024 Earnings Call, Mar 15, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.33% | 11.12M | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-6.63% | 141B |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Inc. Appoints Marc Léger as Director